The Aperio Blog
Aperio is Proud to Sponsor NCBIO’s Life Science & Luncheon Forum
January 10, 2019
There are several new therapies reshaping the way we treat disease. Aperio is proud to sponsor NCBIO’s Life Science and Luncheon Forum on January 31st where leaders from the local Raleigh-Durham community will come together to discuss their cutting-edge technologies in gene therapy, cell therapy, gene editing, and nanotechnology. Speakers will discuss how these therapies work, what companies need to succeed, and pricing/reimbursement models.
Title: Emerging Therapies – Reshaping How We Treat Disease
Date: January 31, 2019
Time: 11:30 a.m. – 1:30 p.m.
Location: NC Biotechnology Center
Panelists:
Michael Dombeck, Vice President of Business Development, Precision BioSciences
Tom Jede, Site Head and Senior Director, Vector Manufacturing, bluebird bio
Susan Nichols, Chief Executive Officer, Falcon Therapeutics
Alden Pritchard, Chief Executive Officer, Kaio Therapy
This is a members only event. For additional information on this event or to register, please click here.
About Aperio Clinical Outcomes
Aperio Clinical Outcomes provides full, customizable clinical research services across multiple therapeutic areas. Dedicated to transparent interactions with clients, Aperio also offers consulting services in Quality Assurance, Strategic Resourcing, and practical application of the latest Clinical Trial Technology.
In an industry flooded with data, metrics and technology, Aperio remains steadfastly focused on the most important part of the process: people. From start-up to close out and every point in between, Aperio works with its partners to deliver outcomes that will improve patient care and save lives.
Aperio Clinical Outcomes.
We make it clear.
